110P Patient preferences for adjuvant endocrine treatment of high-risk HR+/HER2- breast cancer: An adaptive choice-based conjoint analysis study from Germany
Autor: | Wöckel, A., Park-Simon, T-W., Korfel, A., Raab, K., Silberzahn, H., Tesch, H. |
---|---|
Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
Databáze: | ScienceDirect |
Externí odkaz: |